November 18, 2026 | 14:00 CET | Free Livestream on YouTube

International experts will explore the intersection of cancer and sepsis, personalized treatment approaches, immunomodulatory therapies, and the integration of sepsis response into global cancer policy. Join us for this free online event on November 18, 2026, at 14:00 CET.

Cancer patients face particular challenges when developing sepsis. Neutropenia, complex interactions between cancer and the immune system, and the need for tailored treatment approaches make the management of sepsis in this patient population especially challenging.

To address these challenges, the Global Sepsis Alliance (GSA) invites healthcare professionals, researchers, policymakers, cancer specialists, patients, and advocates to join the upcoming World Sepsis Congress (WSC) Satellite Session: “Precision Medicine for Cancer Patients with Sepsis” on November 18, 2026.

This free online event will bring together international experts to discuss the intersecting biology of cancer and sepsis, the specific risks faced by neutropenic patients, and opportunities to personalize treatment through immunomodulatory therapies. The session will also explore how sepsis response can be better integrated into European and global cancer policy, with a particular focus on what patients are asking for.

---

International Experts and Perspectives

Moderated by Simone Mancini, GSA Partnership Lead, (Global Sepsis Alliance, Italy), the session will feature contributions from experts representing leading institutions and organizations across Europe, Asia, and North America.

The program will open with remarks from GSA CEO, Dr. Mariam Jashi, followed by presentations addressing key aspects of sepsis in cancer patients:

• Sepsis – A Deadly Threat for Neutropenic Patients
  Dr. Nveed Chaudhary, Jibraan Chaudhary Sepsis Research Foundation, UK

• Sepsis in Cancer: Understanding the Intersecting Biology and Adapting the Response
  Prof. Naoyuki Matsuda, Nagoya University, Japan

• Can We Personalize the Host Response? Immunomodulation Therapies in Cancer Patients with Sepsis
  Dr. Imrana Malik, MD Anderson Cancer Center, United States

• Integrating Sepsis Response in European and Global Cancer Policy: What Do Patients Ask For?
  Antonella Cardone, Cancer Patients Europe, Belgium (to be confirmed)

The presentations will be followed by a Q&A session, giving participants a chance to engage with the speakers and explore the topics further.

---

Sponsored by Sobi

We thank Sobi for sponsoring this WSC Satellite Session.

Sponsors do not influence the choice of speakers or the content of our events in any way.

---

Register Now

Date: November 18, 2026
Time: 14:00 - 15:30 Central European Standard Time (CET)
Format: Online – Free YouTube Livestream
Registration: Free of charge

---

About World Sepsis Congress

The World Sepsis Congress (WSC) is an initiative of the Global Sepsis Alliance. Since its launch in 2016, the Congress has brought together leading international experts, healthcare professionals, researchers, policymakers, patients, and advocates to share the latest knowledge and advances in sepsis prevention, diagnosis, and treatment.

Through its free online congresses and satellite sessions, the WSC makes sepsis knowledge accessible to audiences worldwide.

Join us on November 18 and be part of the global conversation on improving sepsis care for cancer patients.

The New Zealand Sepsis Trust co-founder Dr Paul Huggan and CEO Ally Hossain with Minister Simeon Brown

A major step forward in the fight against sepsis has been announced today, with Health NZ confirming the development of a nationwide sepsis improvement programme.

The announcement follows years of sustained advocacy from The New Zealand Sepsis Trust and other health sector champions, calling for sepsis to be recognised as a national health priority and for a coordinated approach to improving care.

The initiative aims to strengthen early recognition, standardise treatment pathways and improve outcomes for patients across Aotearoa New Zealand, where sepsis remains a significant cause of preventable death and harm.

The programme will support hospitals and frontline clinicians to implement evidence-based sepsis pathways, improve data collection and reporting, and embed consistent, high-quality care regardless of location.

Importantly, Sepsis Trust NZ will have a seat at the table as the programme moves into implementation, with its CEO (and GSA Board Member), Ally Hossain, and its Chair of its Clinical & Scientific Committee and Trust co-founder, Dr Paul Huggan, appointed to the National Sepsis Governance Committee to oversee the work.

Dr Huggan says the announcement represents a critical milestone following years of advocacy.

“This is a significant and long-awaited step forward.

“For years, we have worked alongside clinicians, families and decision-makers to highlight the devastating impact of sepsis and the urgent need for a coordinated national response.

“Today’s announcement reflects that collective effort. Although it represents a moment of satisfaction for me and the co-founders of our Trust, Dr Robert Martynoga and Dr Dan Dobbins, there is still much to be done,” he says.

CEO Ally Hossain says advocacy has always been about turning the experiences of patients and whānau into meaningful change.

“This is the moment we have been working towards. We have consistently called for sepsis to be treated as a national health priority, and to see a nationwide quality improvement programme now moving forward is a significant milestone for Aotearoa.

“For the Sepsis Trust, we continually hear first-hand what happens when sepsis is missed, treatment is delayed or care varies depending on where you live.

“There is still a lot of work ahead, but this gives us an opportunity to make lasting, system-wide improvements to the way sepsis is recognised and managed. We are proud to have advocated for this change and, through our representation on the governance group, to now be part of helping shape what happens next,” she says.

Sepsis affects thousands of New Zealanders every year and can progress rapidly, leading to organ failure and death if not treated quickly. Survivors can also face significant long-term physical and psychological impacts.

The new programme is expected to:

• Support consistent implementation of sepsis clinical pathways across hospitals

• Improve early detection and timely treatment

• Strengthen workforce capability through training and education

• Improve data collection, measurement and reporting

• Support quality improvement across the health system

• Help reduce variation in sepsis care and improve outcomes for patients and whānau

The rollout of the programme is expected to begin next year, with implementation across all districts.

November 4, 2026 | 14:00 CET | Free Livestream on YouTube

Update Nov 4: The session has concluded; thank you for joining. You can rewatch it above or on YouTube here, with chapter markers, so you can jump directly to the speaker/topic you are most interested in.

---

How can precision diagnostics improve sepsis outcomes? Today, on November 4, 2026, the Global Sepsis Alliance will host a World Sepsis Congress Satellite Session, sponsored by Danaher, bringing together international experts and a sepsis survivor to explore advances in sepsis diagnosis and their potential to save lives.

Sepsis is a life-threatening condition in which early and accurate diagnosis is critical. Yet, despite advances in medical technology, diagnosing sepsis remains challenging. Its diverse clinical presentations, the limitations of current diagnostic approaches, and the need to identify infections and understand individual host responses underscore the need for better diagnostic strategies.

Precision diagnostics offer opportunities to improve how sepsis is recognized, characterized, and treated. This free online session will examine emerging technologies and approaches, from host-response biomarkers and immune signatures to rapid molecular diagnostics and the integration of diagnostic data into clinical decision-making.

Participants will hear from leading experts in sepsis research and clinical care, as well as a sepsis survivor, and explore how diagnostic innovations could support earlier intervention, more targeted antimicrobial treatment, and better patient outcomes.

---

Program and Speakers

The 90-minute session will be moderated by our very own Simone Mancini of the Global Sepsis Alliance, and will feature the following presentations:

The Patient Perspective: Earlier and More Accurate Diagnosis Save Lives
Shahrzad Kiavash, Sepsis Survivor and Paralympic Triathlete, Sweden

The session opens with a personal perspective on sepsis and the importance of timely, accurate diagnosis.

Rethinking Sepsis Diagnosis: From Clinical Syndrome to Precision Diagnostics
Prof. Djillali Annane, IHU Sepsis, France

Why do we need better diagnostics in sepsis, and what should a precision diagnostic actually achieve? This presentation will examine sepsis as a heterogeneous clinical syndrome, the limitations of current diagnostic approaches, and the need to move beyond individual biomarkers or tests toward integrated diagnostic strategies.

Early Diagnosis of Sepsis in the Emergency Room
Prof. Antonio Artigas, Autonomous University of Barcelona, Spain

This presentation will explore the challenges of recognizing sepsis in the emergency room, the importance of early diagnosis, and how improved diagnostic approaches can support timely clinical decisions and better patient outcomes.

Investing in Sepsis Science for Future Pandemic Preparedness
Dr. Mariam Jashi, Global Sepsis Alliance, Georgia

This presentation will highlight the importance of sustained investment in sepsis research and innovation to strengthen health systems, advance scientific knowledge, and improve preparedness for future pandemics.

Integrating Diagnostic Data: From Precision Testing to Clinical Decision-Making
Prof. Alison Fox-Robichaud, McMaster University, Canada

With multiple diagnostic signals available, how can clinicians translate complex data into meaningful clinical decisions? This presentation will explore advances in diagnostic integration and their demonstrated clinical benefits.

The session will conclude with a question-and-answer segment and closing remarks from Simone Mancini.

---

Sponsored by

We thank Danaher for sponsoring this webinar.

Sponsors do not influence the choice of speakers or the content of our events in any way.

We are pleased to invite you to our next lecture on Tuesday, November 3 2026, at 6:00 PM EAT / 3:00 PM GMT / 4:00 PM CET: Delivering ICU-Level Care to Patients with Sepsis Outside the ICU

We are delighted to welcome Dr. Irene Bandoh, MD, Senior Specialist in Intensive Care and Anesthesiology at Komfo Anokye Teaching Hospital in Kumasi, Ghana.

Dr. Bandoh will explore how ICU expertise and intensive care principles can be applied beyond the ICU to support the early recognition and management of sepsis. The lecture will highlight practical approaches to patient assessment, timely treatment, monitoring, and escalation of care.

We warmly invite you to join us for this session and share your questions and experiences.

Registration

If you have not yet registered, please do so using the QR-Code above or here.

CPD Points and E-Certificates

Participants affiliated with the Arsi University CPD Center (Ethiopia) are eligible for CPD points. To register for CPD points via Arsi University, please complete the following form: CPD Registration Form

E-certificates will be issued for the attended lectures.

About the Series

The STAIRS Global Sepsis Lecture Series brings together leading experts from Africa and beyond to support capacity strengthening and knowledge exchange on all aspects of sepsis. With a focus on both adult and pediatric care, the series highlights clinical management from an interprofessional perspective and explores topics such as infection prevention, antimicrobial resistance, telemedicine, and quality improvement.

Lectures are held bi-weekly over 24 months and are open to clinicians, nurses, students, and healthcare professionals across STAIRS partner countries—and beyond. Please feel free to share this invitation widely within your networks.

Missed a Live Session?
All our last sessions have been made available on Learning-STAIRS and YouTube. We encourage you to use these resources and to visit our website for additional content and the latest publications on sepsis in low- and middle-income settings.

November 4, 2026 | 14:00 CET | Free Livestream on YouTube

How can precision diagnostics improve sepsis outcomes? On November 4, 2026, the Global Sepsis Alliance will host a World Sepsis Congress Satellite Session, sponsored by Danaher, bringing together international experts and a sepsis survivor to explore advances in sepsis diagnosis and their potential to save lives.

Sepsis is a life-threatening condition in which early and accurate diagnosis is critical. Yet, despite advances in medical technology, diagnosing sepsis remains challenging. Its diverse clinical presentations, the limitations of current diagnostic approaches, and the need to identify infections and understand individual host responses underscore the need for better diagnostic strategies.

Precision diagnostics offer opportunities to improve how sepsis is recognized, characterized, and treated. This free online session will examine emerging technologies and approaches, from host-response biomarkers and immune signatures to rapid molecular diagnostics and the integration of diagnostic data into clinical decision-making.

Participants will hear from leading experts in sepsis research and clinical care, as well as a sepsis survivor, and explore how diagnostic innovations could support earlier intervention, more targeted antimicrobial treatment, and better patient outcomes.

Register now using the form below to join the discussion.

---

Register Now

---

Program and Speakers

The 90-minute session will be moderated by our very own Simone Mancini of the Global Sepsis Alliance, and will feature the following presentations:

The Patient Perspective: Earlier and More Accurate Diagnosis Save Lives
Shahrzad Kiavash, Sepsis Survivor and Paralympic Triathlete, Sweden

The session opens with a personal perspective on sepsis and the importance of timely, accurate diagnosis.

Rethinking Sepsis Diagnosis: From Clinical Syndrome to Precision Diagnostics
Prof. Djillali Annane, IHU Sepsis, France

Why do we need better diagnostics in sepsis, and what should a precision diagnostic actually achieve? This presentation will examine sepsis as a heterogeneous clinical syndrome, the limitations of current diagnostic approaches, and the need to move beyond individual biomarkers or tests toward integrated diagnostic strategies.

Early Diagnosis of Sepsis in the Emergency Room
Prof. Antonio Artigas, Autonomous University of Barcelona, Spain

This presentation will explore the challenges of recognizing sepsis in the emergency room, the importance of early diagnosis, and how improved diagnostic approaches can support timely clinical decisions and better patient outcomes.

Investing in Sepsis Science for Future Pandemic Preparedness
Dr. Mariam Jashi, Global Sepsis Alliance, Georgia

This presentation will highlight the importance of sustained investment in sepsis research and innovation to strengthen health systems, advance scientific knowledge, and improve preparedness for future pandemics.

Integrating Diagnostic Data: From Precision Testing to Clinical Decision-Making
Prof. Alison Fox-Robichaud, McMaster University, Canada

With multiple diagnostic signals available, how can clinicians translate complex data into meaningful clinical decisions? This presentation will explore advances in diagnostic integration and their demonstrated clinical benefits.

The session will conclude with a question-and-answer segment and closing remarks from Simone Mancini.

---

Sponsored by

We thank Danaher for sponsoring this webinar.

Sponsors do not influence the choice of speakers or the content of our events in any way.

Leading international experts in sepsis, intensive care, and anesthesiology gathered in Batumi, Georgia, for the 9th International Scientific-Practical Conference in Anesthesiology and Intensive Therapy – Geoanesthesia 2026, held on 2–3 October 2026.

Leaders and scientists of the Global Sepsis Alliance (GSA) and the European Sepsis Alliance (ESA), including Dr. Mariam Jashi (Georgia), Prof. Evangelos J. Giamarellos-Bourboulis (Greece), Prof. Djillali Annane (France), Prof. Antonio Artigas (Spain), and Prof. Manu Malbrain (Belgium), made significant contributions to the international scientific program of the conference.

The conference opened with welcoming remarks from prominent healthcare and academic leaders, including:

·       Prof. Ilia Nakashidze – President of Geoanesthesia and Former Vice Speaker of the Parliament of Georgia

·       H.E. Nino Nizharadze - Minister of Health and Social Affairs of the Autonomous Republic of Adjara;

·       Hon. Dr. Mariam Jashi – CEO of the Global Sepsis Alliance, Former Member of Parliament and Deputy Minister of Health of Georgia

·       Hon. Dr. Zaal Mikeladze - Vice Chair of the Health Committee of the Parlaiment of Georgia.

·       Dr. David Sergeenko – Former Minister of Labour Health and Social Affairs of Georgia

·       Prof. Irakli Natroshvili - Rector of Tbilisi State Medical University;

·       Prof. Zaza Bokhua - Head of Continuing Professional Development (CPD), Tbilisi State Medical University, and

·       Prof. Tinatin (Tina) Chikovani - Professor of Medicine and Head of the Department of Immunology, Tbilisi State Medical University

The meeting brought together distinguished clinicians, researchers, and healthcare professionals from Georgia and across Europe to exchange knowledge, discuss emerging scientific evidence, and explore innovative approaches to improving outcomes for critically ill patients.

A major highlight of the conference was its dedicated international scientific program on sepsis, featuring prominent experts associated with the Global Sepsis Alliance (GSA). Their contributions underscored the importance of international collaboration, evidence-based clinical practice, and continued progress toward reducing the global burden of sepsis.

Global Sepsis Alliance Experts at the Forefront of Scientific Discussions

Dr. Mariam Jashi, who also served as a Conference Co-Chair, opened the international sepsis session with a presentation entitled “2030 Global Agenda for Sepsis”. Her presentation placed sepsis within the broader global health agenda, highlighting the importance of coordinated international action and sustained efforts to improve sepsis prevention, recognition, and management.

Prof. Evangelos J. Giamarellos-Bourboulis, Chair of the European Sepsis Alliance (ESA) and GSA Board Member contributed two presentations: “Precision Immunotherapy: An Emerging Hope for Sepsis Management” and “Macrolides for Severe Pneumonia”. His contributions brought attention to innovative treatment strategies and evolving approaches to managing severe infections.

Prof. Djillali Annane, Member of the ESA Executive Committee delivered two important presentations addressing key challenges in sepsis care: “The Use of Corticosteroids in Sepsis” and “Long-Term Sequelae of Sepsis”. These topics highlighted both the complexities of acute sepsis treatment and the importance of recognizing the lasting consequences of sepsis for patients and healthcare systems.

Prof. Antonio Artigas, GSA Board Member and Member of ESA Executive Committee presented “New Insights of Cell Therapy in Sepsis and ARDS”, exploring emerging therapeutic approaches, and “Early Diagnosis of Sepsis in the Emergency Room”, emphasizing the critical role of timely recognition and intervention in improving patient outcomes.

Prof. Manu Malbrain, Vice Chair of European Sepsis Alliance, addressed important aspects of both sepsis treatment and critical care practice through his presentations “The Role for Natural Agents with Anti-inflammatory and Antioxidative Properties in Sepsis? Potential Usefulness of Xanthohumol” and “The Role of Human Factors and Leadership When Implementing Sepsis Stewardship”. His contributions highlighted the importance of exploring novel therapeutic approaches while strengthening clinical leadership and implementation practices.

Advancing Sepsis Care Through International Collaboration

Beyond the contributions of GSA experts, Geoanesthesia 2026 featured a comprehensive scientific program addressing sepsis management, septic shock, emerging biomarkers, organ dysfunction, critical care rehabilitation, and prevention.

Additional presentations explored the Surviving Sepsis Campaign guidelines, extracorporeal life support for refractory sepsis, post-intensive care syndrome, and the challenges of translating scientific advances into everyday clinical practice.

The conference also included parallel scientific sessions dedicated to modern anesthesiology and ultrasound-guided regional anesthesia, providing a multidisciplinary platform for professional education and collaboration.

Strengthening the Global Response to Sepsis

The participation of GSA experts at Geoanesthesia 2026 reflected the importance of bringing global sepsis expertise into regional scientific forums and strengthening connections between international specialists and local healthcare communities.

Through discussions spanning the 2030 Global Agenda for Sepsis, early diagnosis, precision immunotherapy, innovative treatments, long-term outcomes, and sepsis stewardship, the conference highlighted the need for a comprehensive approach to sepsis that extends from prevention and early recognition to acute management and long-term recovery.

The Global Sepsis Alliance welcomes opportunities for scientific exchange and international collaboration that contribute to greater sepsis awareness, stronger healthcare systems, and improved outcomes for patients worldwide.

Update Oct 28: The session has concluded, thank you for joining. You can rewatch it above or on YouTube here, including chapter markers so you can jump directly to the speaker/topic you are most interested in.

---

The Global Sepsis Alliance (GSA) and the Medical Women’s International Association (MWIA) are joining forces for a global webinar to explore ways to improve sepsis prevention, early diagnosis, and treatment for women and girls. Celebrating MWIA’s 107th anniversary, the event will bring together international experts to discuss the intersection of sepsis, women’s health, rapid diagnostics, and antimicrobial resistance (AMR).

Titled “Transforming Sepsis Care in Women: Rapid Diagnostics for Early Diagnosis, AMR Management, and Treatment,” the webinar will highlight the often-under-recognized impact of sepsis on women and girls throughout their lives, from adolescence and the reproductive years through pregnancy, childbirth, postpartum care, and older age.

Sepsis is a life-threatening condition responsible for an estimated 48.9 million cases and 11 million deaths worldwide each year. Maternal sepsis remains an important cause of preventable maternal morbidity and mortality, underscoring the need for earlier recognition, timely intervention, and effective treatment. Rapid diagnostics and appropriate antimicrobial stewardship are essential to improving outcomes and addressing the growing challenge of antimicrobial resistance.

---

Sponsored by

We thank bioMérieux for sponsoring this webinar.

Sponsors do not influence the choice of speakers or the content of our events in any way.

---

An International Program Bridging Research, Clinical Practice, and Advocacy

The webinar will feature expert presentations examining sepsis through the lens of women’s health and global health priorities.

Hon. Dr. Mariam Jashi, CEO of the Global Sepsis Alliance and Secretary General of MWIA, will explore the relationship between women’s health, sepsis, and the 2030 Sustainable Development Goals. Prof. Sheila Myatra, GSA Board Member from India, will examine sepsis throughout the life cycle of women and girls. Prof. Louise Thwaites of the Oxford University Clinical Research Unit in Vietnam will address early detection and antimicrobial resistance stewardship, highlighting the critical importance of timely action to save lives.

A panel discussion moderated by Simone Mancini, Coordinator of Regional Sepsis Alliances at GSA, will bring together MWIA regional leaders to explore key gaps in sepsis prevention, early detection, antimicrobial stewardship, and treatment across different geographical regions.

The panel will feature:

• Dr. Mandakini Megh, MWIA President-Elect 2025–2028 and President of the Association of Medical Women in India

• Dr. Eliza Lo Chin, Executive Director of the American Medical Women’s Association and MWIA Treasurer

• Dr. Joyce Sakala, MWIA Vice President for Near East and Africa 2025–2028

• Dr. Cornelia Tauber-Bachmann, MWIA Vice President for Central Europe 2025–2028

• Dr. Fatima Alves, MWIA Vice President for Latin America 2025–2028

The program will also include opening remarks from GSA and MWIA leadership, an audience Q&A, and closing remarks by Prof. Tex Kissoon, President of the Global Sepsis Alliance, and Dr. Amany Asfour, President of the Medical Women’s International Association.

---

Strengthening Global Action on Sepsis and Women’s Health

This joint initiative builds on GSA and MWIA's global reach and shared commitment to improving health outcomes and advancing advocacy. By connecting clinical expertise, regional perspectives, and global health priorities, the webinar aims to strengthen knowledge of sepsis recognition and management while mobilizing healthcare professionals as advocates and leaders for better sepsis care.

The discussion will also connect efforts to improve sepsis outcomes with the 2030 Agenda for Sustainable Development, emphasizing the importance of addressing sepsis as part of broader action on women’s health and gender equality.

The Global Sepsis Alliance and the Medical Women’s International Association invite healthcare professionals, researchers, advocates, and all those working to improve women’s health to join this global discussion and help advance more equitable, timely, and effective sepsis care worldwide.

October 28, 2026 | 14:00 CET | Free Livestream on YouTube

The Global Sepsis Alliance (GSA) and the Medical Women’s International Association (MWIA) are joining forces for a global webinar to explore ways to improve sepsis prevention, early diagnosis, and treatment for women and girls. Celebrating MWIA’s 107th anniversary, the event will bring together international experts to discuss the intersection of sepsis, women’s health, rapid diagnostics, and antimicrobial resistance (AMR).

Titled “Transforming Sepsis Care in Women: Rapid Diagnostics for Early Diagnosis, AMR Management, and Treatment,” the webinar will highlight the often-under-recognized impact of sepsis on women and girls throughout their lives, from adolescence and the reproductive years through pregnancy, childbirth, postpartum care, and older age.

Sepsis is a life-threatening condition responsible for an estimated 48.9 million cases and 11 million deaths worldwide each year. Maternal sepsis remains an important cause of preventable maternal morbidity and mortality, underscoring the need for earlier recognition, timely intervention, and effective treatment. Rapid diagnostics and appropriate antimicrobial stewardship are essential to improving outcomes and addressing the growing challenge of antimicrobial resistance.

---

Sponsored by

We thank bioMérieux for sponsoring this webinar.

Sponsors do not influence the choice of speakers or the content of our events in any way.

---

Register Now

---

An International Program Bridging Research, Clinical Practice, and Advocacy

The webinar will feature expert presentations examining sepsis through the lens of women’s health and global health priorities.

Hon. Dr. Mariam Jashi, CEO of the Global Sepsis Alliance and Secretary General of MWIA, will explore the relationship between women’s health, sepsis, and the 2030 Sustainable Development Goals. Prof. Sheila Myatra, GSA Board Member from India, will examine sepsis throughout the life cycle of women and girls. Prof. Louise Thwaites of the Oxford University Clinical Research Unit in Vietnam will address early detection and antimicrobial resistance stewardship, highlighting the critical importance of timely action to save lives.

A panel discussion moderated by Simone Mancini, Coordinator of Regional Sepsis Alliances at GSA, will bring together MWIA regional leaders to explore key gaps in sepsis prevention, early detection, antimicrobial stewardship, and treatment across different geographical regions.

The panel will feature:

• Dr. Mandakini Megh, MWIA President-Elect 2025–2028 and President of the Association of Medical Women in India

• Dr. Eliza Lo Chin, Executive Director of the American Medical Women’s Association and MWIA Treasurer

• Dr. Joyce Sakala, MWIA Vice President for Near East and Africa 2025–2028

• Dr. Cornelia Tauber-Bachmann, MWIA Vice President for Central Europe 2025–2028

• Dr. Fatima Alves, MWIA Vice President for Latin America 2025–2028

The program will also include opening remarks from GSA and MWIA leadership, an audience Q&A, and closing remarks by Prof. Tex Kissoon, President of the Global Sepsis Alliance, and Dr. Amany Asfour, President of the Medical Women’s International Association.

---

Strengthening Global Action on Sepsis and Women’s Health

This joint initiative builds on GSA and MWIA's global reach and shared commitment to improving health outcomes and advancing advocacy. By connecting clinical expertise, regional perspectives, and global health priorities, the webinar aims to strengthen knowledge of sepsis recognition and management while mobilizing healthcare professionals as advocates and leaders for better sepsis care.

The discussion will also connect efforts to improve sepsis outcomes with the 2030 Agenda for Sustainable Development, emphasizing the importance of addressing sepsis as part of broader action on women’s health and gender equality.

The Global Sepsis Alliance and the Medical Women’s International Association invite healthcare professionals, researchers, advocates, and all those working to improve women’s health to join this global discussion and help advance more equitable, timely, and effective sepsis care worldwide.